Clinical-radiopathological features and EBV DNA dynamics in nasopharyngeal neuroendocrine carcinoma: implications for prognosis and surveillance
Authors:
- 28 March 2026
- journal article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (7) , 4587-4595
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Fujian Province (2025J01223)
This publication has 41 references indexed in Scilit:
- Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal CarcinomaJAMA, 2025
- Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging ClassificationJAMA Oncology, 2024
- Clinicopathological Features of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma: Analysis of Twenty-Two CasesEndocrine Pathology, 2024
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and NasopharynxHead and Neck Pathology, 2022
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine NeoplasmsHead and Neck Pathology, 2022
- Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsEndocrine Pathology, 2022
- The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaCancer Communications, 2021
- Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†Annals of Oncology, 2021
- Accelerated hyperfractionated radiotherapy for small cell carcinoma of the nasopharynxHead & Neck, 2015
- Nasopharyngeal carcinoma: Orderly neck node spreadInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990